FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

ICH Pharmacoepidemiological Study Guidance Out

[ Price : $8.95]

FDA publishes for comment the International Council for Harmonization M14 guidance on general principles for planning, designing, ...

Sanofi Sarclisa sBLA Accepted for Priority Review

[ Price : $8.95]

FDA accepts for priority review a Sanofi supplemental BLA for Sarclisa (isatuximab) in combination with standard of care for treat...

Workshop on Patient-Generated Health Data

[ Price : $8.95]

FDA co-sponsors a 6/26-27 public workshop on using patient-generated health data in medical device development.

Platform Technology Designation Guidance

[ Price : $8.95]

FDA publishes a draft guidance on the drug development platform technology designation program.

FDA Seeks to Withdraw 4 NDAs

[ Price : $8.95]

Federal Register notice: CDER proposes to withdraw approval of four NDAs after the application holders repeatedly failed to file r...

Pfizer Wins Priority Review Voucher for Paxlovid

[ Price : $8.95]

Federal Register notice: FDA issues a priority review voucher to Pfizer after determining that its Paxlovid tablets meet the crite...

Lawmakers Want FDA Jurisdiction on Execution Drugs

[ Price : $8.95]

Senators Cory Booker (D-NJ) and Elizabeth Warren (D-MA) urge the Department of Justice to rescind its Office of Legal Counsels 201...

Palacio Debarred Over FDA False Statements

[ Price : $8.95]

Federal Register notice: FDA permanently debars Jessica Palacio from providing services to any person that has approved or pending...

Respironics Recalls OmniLab Ventilator

[ Price : $8.95]

Philips Respironics recalls (Class 1) its OmniLab Advanced + Ventilator because the device may experience an interruption or loss ...

Panel Backs Shield Colon Cancer Test

[ Price : $8.95]

An FDA advisory committee recommends the approval of a Guardant Health PMA for the Shield blood test for colorectal cancer screeni...